Immediate Impact
17 standout
Citing Papers
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
Works of Yiling Yu being referenced
P1219: BGB-16673, A BTK DEGRADER, OVERCOMES ON-TARGET RESISTANCE FROM BTK INHIBITORS AND PRESENTS SUSTAINABLE LONG-TERM TUMOR REGRESSION IN LYMPHOMA XENOGRAFT MODELS
2023
The Prognostic Significance of CD79B Mutation in Diffuse Large B-Cell Lymphoma: A Meta-analysis and Systematic Literature Review
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Yiling Yu | 118 | 113 | 45 | 8 | 147 | |
| Chiara Lobetti Bodoni | 101 | 108 | 25 | 8 | 184 | |
| Sabrina Leonetti Crescenzi | 167 | 146 | 43 | 6 | 175 | |
| Martyn Ronald Schaafsma | 69 | 50 | 28 | 11 | 171 | |
| Maité Cabes | 98 | 94 | 18 | 9 | 137 | |
| Anouk de Jong | 96 | 64 | 38 | 7 | 111 | |
| Sean D. Reiff | 127 | 98 | 57 | 12 | 155 | |
| Erica B. Bhavsar | 78 | 61 | 19 | 10 | 115 | |
| Jodi Carey | 115 | 108 | 99 | 11 | 210 | |
| Krista M. Isaac | 60 | 59 | 23 | 11 | 103 | |
| C-M Wendtner | 84 | 57 | 23 | 5 | 148 |
All Works
Login with ORCID to disown or claim papers
Loading papers...